Abstract
Background and aims
Burning mouth syndrome (BMS) and atypical facial pain (AFP) are often persistent idiopathic pain conditions that mainly affect middle-aged and elderly women. They have both been associated with various psychiatric disorders. This study examined current and lifetime prevalence of psychiatric axis I (symptom-based) and II (personality) disorders in patients with chronic idiopathic orofacial pain, and investigated the temporal relationship of psychiatric disorders and the onset of orofacial pain.
Method
Forty patients with BMS and 23 patients with AFP were recruited from Turku university hospital clinics. Mean age of the patients was 62.3 years (range 35–84) and 90% were female. BMS and AFP diagnoses were based on thorough clinical evaluation, and all patients had undergone clinical neurophysiological investigations including blink reflex and thermal quantitative tests. Current and lifetime DSM-IV diagnoses of axis I and II disorders were made on clinical basis with the aid of SCID-I and II-interviews. The detected prevalence rates and their 95% confidence intervals based on binomial distribution were compared to three previous large population-based studies.
Results
Of the 63 patients, 26 (41.3%) had had an axis I disorder that preceded the onset of orofacial pain, and 33 (52.4%) had had a lifetime axis I disorder. Rate of current axis I disorders was 36.5%, indicating that only about 16% of lifetime disorders had remitted, and they tended to run chronic course. The most common lifetime axis I disorders were major depression (30.2%), social phobia (15.9%), specific phobia (11.1%), and panic disorder (7.9%). Twelve patients (19.0%) had at least one cluster C personality disorder already before the emergence of orofacial pain. Patients with cluster C personality disorders are characterized as fearful and neurotic. None of the patients had cluster A (characterized as odd and eccentric) or B (characterized as dramatic, emotional or erratic) personality disorders. The most common personality disorders were obsessive–compulsive personality (14.3%), dependent personality (4.8%), and avoidant personality (3.2%). The majority of the patients (54%) had also one or more chronic pain conditions other than orofacial pain. In almost all patients (94%) they were already present at the onset of orofacial pain.
Conclusions
Our results suggest that major depression, persistent social phobia, and neurotic, fearful, and obsessive–compulsive personality characteristics are common in patients with chronic idiopathic orofacial pain. Most psychiatric disorders precede the onset of orofacial pain and they tend to run a chronic course.
Implications
We propose that the high psychiatric morbidity, and comorbidity to other chronic pain conditions, in chronic idiopathic orofacial pain can be best understood in terms of shared vulnerability to both chronic pain and specific psychiatric disorders, most likely mediated by dysfunctional brain dopamine activity.
DOI of refers to article: 10.1016/j.sjpain.2011.08.003.
Acknowledgements
This study was supported by the Finnish Medical Foundation and the Sigrid Juselius Foundation.
References
[1] Woda A, Pionchon P. A unified concept of idiopathic orofacial pain: clinical features. J Orofac Pain 1999;13:172–84.Search in Google Scholar PubMed
[2] Woda A, Tubert-Jeannin S, Bouhassira D, Attal N, Fleiter B, Goulet J-P, Gremeau-Richard C, Navez ML, Picard P, Pionchon P, Albuisson E. Towards a new taxonomy of idiopathic orofacial pain. Pain 2005;116:396–406.10.1016/j.pain.2005.05.009Search in Google Scholar PubMed
[3] Bergdahl M, Bergdahl J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med 1999;28:350–4.10.1111/j.1600-0714.1999.tb02052.xSearch in Google Scholar PubMed
[4] Scala A, Checchi L, Montevecchi M, Marini I. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003;14:275–91.10.1177/154411130301400405Search in Google Scholar PubMed
[5] Bergdahl J, Anneroth G. Burning mouth syndrome: literature review and model for research and management. J Oral Pathol Med 1993;22:433–8.10.1111/j.1600-0714.1993.tb00120.xSearch in Google Scholar PubMed
[6] Lipton JA, Ship JA, Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Den Assoc 1993;124:115–21.10.14219/jada.archive.1993.0200Search in Google Scholar
[7] Forssell H, Tenovuo O, Silvoniemi P, Jääskeläinen S. Differences and similarities between atypical facial pain and trigeminal neuropathic pain. Neurology 2007;69:1451–9.10.1212/01.wnl.0000277274.83301.c0Search in Google Scholar PubMed
[8] Jääskeläinen SK, Rinne JO, Forssell H, Tenovuo O, Kaasinen V, Sonninen P, Bergman J. Role of dopaminergic system in chronic pain—a fluorodopa-PET study. Pain 2001;90:257–60.10.1016/S0304-3959(00)00409-7Search in Google Scholar PubMed
[9] Hagelberg N, Forssell H, Aalto S, Rinne JO, Scheinin H, Taiminen T, Aalto S, Luutonen S, Någren K, Jääskeläinen S. Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain 2003;101:149–54.10.1016/S0304-3959(02)00323-8Search in Google Scholar PubMed
[10] Hagelberg N, Forssell H, Aalto S, Rinne JO, Scheinin H, Taiminen T, Någren K, Eskola O, Jääskeläinen SK. Altered dopamine D2 receptor binding in atypical facial pain. Pain 2003;106:43–8.10.1016/S0304-3959(03)00275-6Search in Google Scholar PubMed
[11] Derbyshire SWG, Jones AKP, Devani P, Friston KJ, Feinman C, Harris M, Pearce S, Watson JD, Frackowiak RS. Cerebral responses to pain in patients with atypical facial pain measured by positron emission tomography. J Neurol Neurosurg Psychiatry 1994;57:1166–72.10.1136/jnnp.57.10.1166Search in Google Scholar PubMed PubMed Central
[12] Albuquerque RJC, de Leeuw R, Carlson CR, Okeson JP, Miller CS, Andersen AH. Cerebral activation during thermal stimulation of patients who have burning mouth disorder: an fMRI study. Pain 2006;122:223–34.10.1016/j.pain.2006.01.020Search in Google Scholar PubMed
[13] Forssell H, Jääskeläinen S, Tenovuo O, Hinkka S. Sensory dysfunction in burning mouth syndrome. Pain 2002;99:41–7.10.1016/S0304-3959(02)00052-0Search in Google Scholar PubMed
[14] Lauria G, Majorana A, Borgna M, Lombardi R, Penza P, Padovani A, Sapelli P. Trigeminal small-fibre sensory neuropathy causes burning mouth syndrome. Pain 2005;115:332–7.10.1016/j.pain.2005.03.028Search in Google Scholar
[15] Yilmaz Z, Renton T, Yiangou Y, Zakrzewska J, Chessell IP, Bountra C, Anand P. Burning mouth syndrome as a trigeminal small fibre neuropathy: increased heat and capsaicin receptor TRPV1 in nerve fibres correlates with pain score. J Clin Neurosci 2007;14:864–71.10.1016/j.jocn.2006.09.002Search in Google Scholar PubMed
[16] Greméau-Richard C, Dubray C, Aublet-Cuvelier B, Ughetto S, Woda A. Effect of lingual nerve block on burning mouth syndrome (stomatodynia): a randomized controlled trial. Pain 2010;149:27–32.10.1016/j.pain.2009.11.016Search in Google Scholar PubMed
[17] Gilpin SF. Glossodynia. JAMA 1936;106:1722–4.10.1001/jama.1936.02770200028010Search in Google Scholar
[18] Lascelles RG. Atypical facial pain and depression. Br J Psychiatry 1966;112:651–9.10.1192/bjp.112.488.651Search in Google Scholar PubMed
[19] Feinmann C, Harris M, Cawley R. Psychogenic facial pain: presentation and treatment. BMJ 1984;288:436–8.10.1136/bmj.288.6415.436Search in Google Scholar
[20] Ott G, Ott C. Glossodynia—psychodynamic basis and results of psychopathometric investigations. J Psychosomatic Res 1992;36:677–86.10.1016/0022-3999(92)90057-9Search in Google Scholar
[21] Remick RA, Blasberg B, Campos PE, Miles JE. Psychiatric disorders associated with atypical facial pain. Can J Psychiatry 1983;28:178–81.10.1177/070674378302800304Search in Google Scholar PubMed
[22] Rojo L, Silvestre FJ, Bagan JV, De Vicente T. Psychiatric morbidity in burning mouth syndrome. Psychiatric interview versus depression and anxiety scales. Oral Surg Oral Med Oral Pathol 1993;75:308–11.10.1016/0030-4220(93)90142-QSearch in Google Scholar PubMed
[23] Rojo L, Silvestre FJ, Bagan JV. Prevalence of psychopathology in burning mouth syndrome. A comparative study among patients with and without psychiatric disorders and controls. Oral Surg Oral Med Oral Pathol 1994;73:312–6.10.1016/0030-4220(94)90060-4Search in Google Scholar
[24] Bogetto F, Maina G, Ferro G, Carbone M, Gandolfo S. Psychiatric comorbidity in patients with burning mouth syndrome. Psychosom Med 1998;60:378–85.10.1097/00006842-199805000-00028Search in Google Scholar PubMed
[25] Nicholson M, Wilkinson G, Field E, Longman L, Fitzgerald B. A pilot study: stability of psychiatric diagnoses over 6 months in burning mouth syndrome. J Psychosom Res 2000;49:1–2.10.1016/S0022-3999(99)00056-2Search in Google Scholar PubMed
[26] Lang E, Kaltenhäuser M, Seidler S, Mattenklodt P, Neundörfer B. Persistent idiopathic facial pain exists independent of somatosensory input from the painful region: findings from quantitative sensory functions and somatotopy of the primary somatosensory cortex. Pain 2005;118:80–91.10.1016/j.pain.2005.07.014Search in Google Scholar PubMed
[27] Solomon S, Lipton RB. Atypical facial pain: a review. Semin Neurol 1988;8:332–8.10.1055/s-2008-1041398Search in Google Scholar PubMed
[28] Gouda JJ, Brown JA. Atypical facial pain and other pain syndromes. Neurosurg Clin North Am 1997;8:87–100.10.1016/S1042-3680(18)30339-5Search in Google Scholar
[29] Bergdahl J, Anneroth G, Perris H. Personality characteristics of patients with resistant burning mouth syndrome. Acta Odontol Scand 1995;53:7–11.10.3109/00016359509005936Search in Google Scholar PubMed
[30] Trikkas G, Nikolatou O, Samara C, Bazopoulou-Kyrkanodou E, Rabavilas AD, Christodoulou GN. Glossodynia: personality characteristics and psychopathology. Psychother Psychosom 1996;65:163–8.10.1159/000289070Search in Google Scholar PubMed
[31] Maina G, Albert U, Gandolfo S, Vitalucci A, Bogetto F. Personality disorders in patients with burning mouth syndrome. J Personal Disord 2005;19:84–93.10.1521/pedi.19.1.84.62182Search in Google Scholar PubMed
[32] Jääskeläinen SK, Forssell H, Tenovuo O. Electrophysiological testing of the trigeminofacial system: aid in the diagnosis of atypical facial pain. Pain 1999;80:191–200.10.1016/S0304-3959(98)00203-6Search in Google Scholar
[33] American Psychiatric Association, editor. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. Washington, DC: APA; 1994.Search in Google Scholar
[34] First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV axis I disorders (SCID-I, 4/97 version). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1997.Search in Google Scholar
[35] First MB, Spitzer RL, Gibbon M, Williams JBW, Benjamin L. Structured clinical interview for DSM-IV axis II disorders (SCID-II). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1997.Search in Google Scholar
[36] Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617–27.10.1001/archpsyc.62.6.617Search in Google Scholar PubMed
[37] Kessler RC, Berglund P, Demler O, Jin R, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593–602.10.1001/archpsyc.62.6.593Search in Google Scholar PubMed
[38] Pirkola SP, Isometsä E, Suvisaari J, Aro H, Joukamaa M, Poikolainen K, Koskinen S, Aromaa A, Lönnqvist J. DSM-IV mood-, anxietyand alcohol use disorders and their comorbidity in the Finnish general population: results from the Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol 2005;40:1–10.10.1007/s00127-005-0848-7Search in Google Scholar
[39] Lenzenweger MF, Lane MC, Loranger AW, Kessler RC. DSM-IV personality disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007;62:553–64.10.1016/j.biopsych.2006.09.019Search in Google Scholar PubMed
[40] Lamey P-J, Lamb AB. Prospective study of aetiological factors in burning mouth syndrome. BMJ 1988;296:1243–6.10.1136/bmj.296.6631.1243Search in Google Scholar
[41] Reich J, Nduaguba M, Yates W. Age and sex distribution of DCM III personality cluster traits in a community population. Compr Psychiatry 1988;29: 298–303.10.1016/0010-440X(88)90052-1Search in Google Scholar
[42] Uguz F, Cicek E, Salli A, Karahan AY, Albayrak I, Kaya N, Ugurlu H. Axis I and II psychiatric disorders in patients with fibromyalgia. Gen Hosp Psychiatry 2010;32:105–7.10.1016/j.genhosppsych.2009.07.002Search in Google Scholar PubMed
[43] Ohayon MM, Scatzberg AF. Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry 2003;60:39–47.10.1001/archpsyc.60.1.39Search in Google Scholar PubMed
[44] Türp JC, Kowalski CJ, O’Leary N, Stohler CS. Pain maps from facial pain patients indicate a broad pain geography. J Dent Res 1998;77:1465–72.10.1177/00220345980770061101Search in Google Scholar PubMed
[45] Dersh J, Polatin PB, Gatchel RJ. Chronic pain and psychopathology: research findings and theoretical considerations. Psychosom Med 2002;64:773–86.10.1097/00006842-200209000-00010Search in Google Scholar PubMed
[46] Diatchenko L, Nackley AG, Slade GD, Fillingim RB, Maixner W. Idiopathic pain disorders—pathways of vulnerability. Pain 2006;123:226–30.10.1016/j.pain.2006.04.015Search in Google Scholar PubMed
[47] Jääskeläinen SK, Forssell H, Tenovuo O. Abnormalities of the blink reflex in burning mouth syndrome. Pain 1997;73:455–60.10.1016/S0304-3959(97)00140-1Search in Google Scholar PubMed
[48] Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D. COMT val158 met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003;299:1240–3.10.1126/science.1078546Search in Google Scholar PubMed
[49] Wood PB. Stress and dopamine: implications for the pathophysiology of chronic widespread pain. Med Hypothesis 2004;62:420–4.10.1016/j.mehy.2003.10.013Search in Google Scholar PubMed
[50] Strigo IA, Simmons AN, Matthews SC, Craig AD, Paulus MP. Association of major depressive disorder with altered functional brain response during anticipation and processing of heat pain. Arch Gen Psychiatry 1998;65:1275–84.10.1001/archpsyc.65.11.1275Search in Google Scholar PubMed PubMed Central
[51] Borsook D, Becerra L, Carlezon WA, Shaw M, Renshaw P, Elman I, Levine J. Reward-aversion circuitry in analgesia and pain: implications for psychiatric disorders. Eur J Pain 2007;11:7–20.10.1016/j.ejpain.2005.12.005Search in Google Scholar PubMed
[52] Tiihonen J, Kuikka J, Bergström K, Lepola U, Koponen H, Leinonen E. Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry 1997;154:239–42.10.1176/ajp.154.2.239Search in Google Scholar PubMed
[53] Lambert G, Johansson M, Ågren H, Friberg P. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness. Arch Gen Psychiatry 2000;57:787–93.10.1001/archpsyc.57.8.787Search in Google Scholar PubMed
[54] Schneier FR, Liebowitch MR, Abi-Dargham A, Zea-Ponce Y, Lin SH, Laruelle M. Low dopamine D2 receptor binding potential in social phobia. Am J Psychiatry 2000;157:457–9.10.1176/appi.ajp.157.3.457Search in Google Scholar PubMed
[55] Klimek V, Schenck JE, Han H, Stockmeier CA, Ordway GA. Dopaminergic abnormalities in amygdaloid nuclei in major depression: a post-mortem study. Biol Psychiatry 2002;52:740–8.10.1016/S0006-3223(02)01383-5Search in Google Scholar
[56] Meyer JH, Ginovart N, Boovariwala A, Sagrati S, Hussey D, Garcia A, Young T, Praschak-Rieder N, Wilson AA, Houele S. Elevated monoamine oxidase A levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 2006;63:1209–16.10.1001/archpsyc.63.11.1209Search in Google Scholar PubMed
[57] Olver JS, O’Keefe G, Jones GR, Burrows GD, Tochon-Danguy HJ, Ackermann U, Scott A, Norman TR. Dopamine D1 receptor binding in the striatum of patients with obsessive–compulsive disorder. J Affect Disord 2009;114:321–6.10.1016/j.jad.2008.06.020Search in Google Scholar PubMed
[58] Perani D, Garibotto V, Gprini A, Moresco RM, Henin M, Panzacchi A, Matarrese M, Carpinelli A, Ballodi L, Fazio F. In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naïve obsessive–compulsive disorder. Neuroimage 2008;42:306–14.10.1016/j.neuroimage.2008.04.233Search in Google Scholar PubMed
[59] Tomer R, Aharon-Petez J. Novelty seeking and harm avoidance in Parkinson’s disease: effects of asymmetric dopamine deficiency. J Neurol Neurosurg Psychiatry 2004;75:972–5.10.1136/jnnp.2003.024885Search in Google Scholar PubMed PubMed Central
[60] Conrad R, Schilling G, Bausch C, Nadstawek J, Wartenberg HC, Wegener I, Geiser F, Imbierowicz K, Liedtke R. Temperament and character personality profiles and personality disorders in chronic pain patients. Pain 2007;133: 197–209.10.1016/j.pain.2007.07.024Search in Google Scholar PubMed
[61] Nyman ES, Loukola A, Varolo T, Ekelund J, Veijola J, Joukamaa M, Taanila A, Pouta A, Miettunen J, Freimer N, Järvelin M-R, Peltonen L. Impact of the dopamine receptor gene family on temperament traits in a population-based cohort. Am J Med Genet B Neuropsychiatr Genet 2009;150:854–65.10.1002/ajmg.b.30908Search in Google Scholar PubMed
[62] Zald DH, Cowan RL, Riccardi P, Baldwin RM, Ansari MS, Li R, Shelby ES, Smith CE, McHugo M, Kessler RM. Midbrain dopamine receptor availability is inversely associated with novelty-seeking traits in humans. J Neurosci 2008;28: 14372–8.10.1523/JNEUROSCI.2423-08.2008Search in Google Scholar PubMed PubMed Central
[63] Hess C, Reif A, Strobel A, Boreatti-Hümmer A, Heine M, Lesch K-P, Jacop CP. A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders. J Neural Transm 2009;116:121–30.10.1007/s00702-008-0138-0Search in Google Scholar PubMed
[64] Defazio G, Bearardelli A, Fabbrini G, Martino D, Fincati E, Fiaschi A, Moretto G, Abbruzzese G, Marchese R, Bonuccelli U, Del Dotto P, Barone P, De Vivo E, Albanese A, Antonini A, Canesi M, Lopiano L, Zibetti M, Nappi G, Martignoni E, Lamberti P, Tinazzi M. Pain as a nonmotor symptom of Parkinson disease. Arch Neurol 2008;65:1191–4.10.1001/archneurol.2008.2Search in Google Scholar PubMed
[65] Magnusson JE, Fisher K. The involvement of dopamine in nociception: the role of D1 and D2 receptors in the dorsolateral striatum. Brain Res 2000;855: 260–6.10.1016/S0006-8993(99)02396-3Search in Google Scholar PubMed
[66] Hagelberg N, Jääskeläinen SK, Martikainen IK, Mansikka H, Forssell H, Scheinin H, Hietala J, Pertovaara A. Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur J Pharmacol 2004;500:187–92.10.1016/j.ejphar.2004.07.024Search in Google Scholar PubMed
[67] Burkey AR, Carstens E, Jasmin L. Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception. J Neurosci 1999;19:4169–79.10.1523/JNEUROSCI.19-10-04169.1999Search in Google Scholar PubMed
[68] Wood PB, Schweinhardt P, Jaeger E, Dagher A, Hakyemez H, Rabiner EA, Bushnell MC, Chizh BA. Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci 2007;25:3576–82.10.1111/j.1460-9568.2007.05623.xSearch in Google Scholar PubMed
[69] Wood PB, Patterson II JC, Sunderland JJ, Tainter KH, Glabus MF, Lilien DL. Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study. J Pain 2007;8:51–8.10.1016/j.jpain.2006.05.014Search in Google Scholar PubMed
[70] Scherman D, Desnos C, Darchen F, Pollack P, Javoy-Agid F, Agid Y. Striatal dopamine deficiency in Parkinson’s disease: role of aging. Ann Neurol 1989;26:551–7.10.1002/ana.410260409Search in Google Scholar PubMed
[71] Rinne JO, Hietala J, Ruotsalainen U, Saki E, Laihnen A, Någren K, Lehikoinen P, Oikonen V, Syvälahti E. Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C] raclopride. J Cereb Blood Flow Metab 1993;13:310–4.10.1038/jcbfm.1993.39Search in Google Scholar PubMed
[72] Bäckman L, Ginovart N, Dixon RA, Robins Wahlin T-B, Wahlin Å, Halldin C, Farde L. Age-related cognitive deficits mediated by changes in the striatal dopamine system. Am J Psychiatry 2000;157:635–7.10.1176/ajp.157.4.635Search in Google Scholar PubMed
[73] Pohjalainen T, Rinne JO, Någren K, Syvälaht E, Hietala J. Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo. Am J Psychiatry 1998;155:768–73.Search in Google Scholar PubMed
[74] Kaasinen V, Någren K, Hietala J, Farde L, Rinne JO. Sex differences in extrastriatal dopamine D2 -like receptors in the human brain. Am J Psychiatry 2001;158:308–11.10.1176/appi.ajp.158.2.308Search in Google Scholar PubMed
[75] Di Paolo T. Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 1994;5:27–42.10.1515/REVNEURO.1994.5.1.27Search in Google Scholar PubMed
[76] Koponen S, Taiminen T, Portin R, Himanen L, Isoniemi H, Heinonen H, Hinkka S, Tenovuo O. Axis I and II psychiatric disorders after traumatic brain injury: a 30-year follow-up study. Am J Psychiatry 2002;159:1315–21.10.1176/appi.ajp.159.8.1315Search in Google Scholar PubMed
© 2011 Scandinavian Association for the Study of Pain
